South Wales, May 1 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "GNL GRACE" on April 9. The details about the trademark application no. UK00004370619 published in the journal no. 2026/018 (May 1).
The Glucose Never Lies Limited filed the trademark application for the below mentioned good(s)/service(s).
Class 9 : Software and downloadable tech. Downloadable computer software for providing artificial intelligence-based educational information about type 1 diabetes; downloadable computer software in the nature of an embeddable chatbot widget for third-party websites; downloadable application programming interfaces (APIs) for the provision of educational content about diabetes; downloadable computer software for accessing, searching and retrieving educational information from curated medical knowledge bases; downloadable computer software for artificial intelligence natural language processing; downloadable mobile applications for type 1 diabetes education.
Class 41 : Education services. Providing online educational information and materials relating to type 1 diabetes; providing non-downloadable educational information in the field of diabetes management via an artificial intelligence chatbot; publication of educational texts and materials; providing interactive educational tools and resources in the field of type 1 diabetes; educational services in the form of online content about insulin, glucose monitoring, continuous glucose monitoring, exercise, nutrition and diabetes devices; provision of educational information via a knowledge base powered by real-world research data.
Class 42 : SaaS and hosted software. Software as a service (SaaS) featuring software for providing educational information about type 1 diabetes via an artificial intelligence chatbot; platform as a service (PaaS) featuring software platforms for embedding educational chatbots into third-party websites; hosting of software applications for others in the field of diabetes education; hosting of computer application programming interfaces (APIs); scientific and technological research in the field of type 1 diabetes; design and development of computer software for artificial intelligence; providing temporary use of non-downloadable software for accessing curated medical knowledge bases.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004370619
Disclaimer: Curated by HT Syndication.
